首页 | 本学科首页   官方微博 | 高级检索  
检索        

卡托普利对大鼠心肌组织丝裂素活化蛋白激酶表达的影响
引用本文:孙银平,白桦,邢东琦,吴立玲.卡托普利对大鼠心肌组织丝裂素活化蛋白激酶表达的影响[J].新乡医学院学报,2001,18(5):311-312.
作者姓名:孙银平  白桦  邢东琦  吴立玲
作者单位:1. 新乡医学院病理生理学教研室
2. 北京医科大学病理生理学教研室
摘    要:目的 探讨卡托普利对肾性高血压大鼠心肌组织丝裂素活化蛋白激酶 (MAPK)表达的影响。方法 复制二肾一夹高血压动物模型作为实验组 ,术后 4周开始给予卡托普利者作为治疗组 ,以未进行二肾一夹者为对照组。术后 8周测定动脉血压、心肌肥大指数及心肌组织MAPK的表达。结果 与对照组相比 ,实验组动脉血压及心肌肥大指数显著升高 ,MAPK表达显著增强 (P <0 .0 1) ;卡托普利显著降低心肌MAPK的表达。结论 心肌MAPK表达增强可能是血管紧张素II介导的心肌肥大信号转导通路中的重要环节。

关 键 词:血管紧张素II  丝裂素活化蛋白激酶  心肌肥大
文章编号:1004-7239(2001)05-0311-02
修稿时间:2001年7月11日

Affects of captopril on expression of mitogen-activated proten kinase in myocardium of renal hypertension rats
SUN Yin-ping ,BAI Hua ,XING Dong-qi ,et al.Affects of captopril on expression of mitogen-activated proten kinase in myocardium of renal hypertension rats[J].Journal of Xinxiang Medical College,2001,18(5):311-312.
Authors:SUN Yin-ping  BAI Hua  XING Dong-qi  
Institution:SUN Yin-ping 1,BAI Hua 2,XING Dong-qi 2,et al
Abstract:Objective To investigate the affects of captopril on expression of mitogen-activated proten kinase (MAPK) in hypertrophic myocardium of renal hypertension rats.Method The rats modle of renal hypertension were made by two-kidney, one-clip as experiment group, the animals with captopril treatment at 4~8 weeks as treatment group, the animal with non-operation as control group.The blood pressure, cardiac hypertrophy parameter and expression of MAPK in myocardium were measured at eighth week. Results The blood pressure, cardiac hypertrophy parameter and expression of MAPK increased significantly in experiment group compared with control group at eighth week(P<0.01).The expression of MAPK significantly decreased in treatment group with captopril.Conclusion Maybe the expression of increased MAPK induced by AngII play an important role in single transduction pathway of hypertrophic myocardium in renal hypertension
Keywords:angiotension II  mitogen-activated proten kinase  myocardiac hypertrophy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号